1. Kuwanon G (Moracenin B) as dual inhibitors of PTP1B and alpha-glucosidase enzymes, as well as insulin sensitizers, it may potentially be utilized as an effective treatment for Type II diabetes mellitus. 2. Kuwanon G has anti-inflammatory activity, it can attenuate atherosclerosis through inhibiting foam cell formation and inflammatory response. 3. Kuwanon G is a potent inhibitor of Mycobacterium tuberculosis protein tyrosine phosphatase B. 4. Kuwanon G shows acetylcholinesterase (AChE) and butyrylcholinesterase(BChE) inhibitory activities, it may be a promising candidate for preventive and therapeutic agents for Alzheimers disease. 5. Kuwanon G prevents the pathological progression of allergic asthma through the inhibition of lung destruction by inflammation and immune stimulation. 6. Kuwanon G has antibacterial activity against oral pathogens. 7. Kuwanon G is a specific antagonist for the GRP-preferring receptor and can be useful for studying the physiological and pathological role of GRP.
Molecular Weight:
692.71
Purity:
98.00%
CAS Number:
[75629-19-5]
Formula:
C40H36O11
Target:
PI3K|||Phosphatase|||Apoptosis|||GSK-3|||NF-kappaB|||ROS|||Akt|||Antibacterial|||MMP|||AChR|||Liver X Receptor|||mTOR|||Glucosidase|||Cholinesterase (ChE)|||Bombesin Receptor
T3S1612
* VAT and and shipping costs not included. Errors and price changes excepted
